Literature DB >> 24488568

Rituximab in the treatment of refractory pulmonary sarcoidosis.

Nadera J Sweiss1, Elyse E Lower, Mehdi Mirsaeidi, Steven Dudek, Joe G N Garcia, David Perkins, Patricia W Finn, Robert P Baughman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24488568      PMCID： PMC4167390          DOI： 10.1183/09031936.00224513

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  12 in total

1.  Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the AutoImmunity and Rituximab Registry.

Authors:  X Puéchal; J E Gottenberg; J M Berthelot; L Gossec; O Meyer; J Morel; D Wendling; M de Bandt; E Houvenagel; B Jamard; T Lequerré; G Morel; P Richette; J Sellam; L Guillevin; X Mariette
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-03       Impact factor: 4.794

Review 2.  Therapy for sarcoidosis: evidence-based recommendations.

Authors:  Robert P Baughman; Hilario Nunes
Journal:  Expert Rev Clin Immunol       Date:  2012-01       Impact factor: 4.473

3.  A case of neurosarcoidosis successfully treated with rituximab.

Authors:  Roberto Bomprezzi; Sandipan Pati; Chakorn Chansakul; Timothy Vollmer
Journal:  Neurology       Date:  2010-08-10       Impact factor: 9.910

Review 4.  Nonsteroidal therapy of sarcoidosis.

Authors:  Peter Korsten; Mehdi Mirsaeidi; Nadera J Sweiss
Journal:  Curr Opin Pulm Med       Date:  2013-09       Impact factor: 3.155

5.  Rituximab as a treatment alternative in sarcoidosis.

Authors:  Ahlam Belkhou; Rachid Younsi; Imane El Bouchti; Selma El Hassani
Journal:  Joint Bone Spine       Date:  2008-06-17       Impact factor: 4.929

6.  Study of immune complexes in bronchoalveolar lavage fluids.

Authors:  P P Dall'Aglio; A Pesci; G Bertorelli; E Brianti; S Scarpa
Journal:  Respiration       Date:  1988       Impact factor: 3.580

7.  Disturbed homeostasis and multiple signaling defects in the peripheral blood B-cell compartment of patients with severe chronic sarcoidosis.

Authors:  Nam-Sihk Lee; Laura Barber; Shaw M Akula; George Sigounas; Yash P Kataria; Sergio Arce
Journal:  Clin Vaccine Immunol       Date:  2011-06-08

8.  Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.

Authors:  M E Reff; K Carner; K S Chambers; P C Chinn; J E Leonard; R Raab; R A Newman; N Hanna; D R Anderson
Journal:  Blood       Date:  1994-01-15       Impact factor: 22.113

Review 9.  Sarcoidosis, role of tumor necrosis factor inhibitors and other biologic agents, past, present, and future concepts.

Authors:  Nadera J Sweiss; James Curran; Robert P Baughman
Journal:  Clin Dermatol       Date:  2007 May-Jun       Impact factor: 3.541

10.  Rituximab for refractory granulomatous eye disease.

Authors:  Elyse E Lower; Robert P Baughman; Adam H Kaufman
Journal:  Clin Ophthalmol       Date:  2012-10-05
View more
  36 in total

1.  Key management considerations in sarcoidosis from the American Thoracic Society 2016 Conference.

Authors:  Ni-Cheng Liang; Kim-Thuy Truong; Kamyar Afshar
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

Review 2.  Potential immunotherapies for sarcoidosis.

Authors:  Van Le; Elliott D Crouser
Journal:  Expert Opin Biol Ther       Date:  2018-01-17       Impact factor: 4.388

Review 3.  The continuing evolution of targeted therapy for inflammatory skin disease.

Authors:  C Schlapbach; A A Navarini
Journal:  Semin Immunopathol       Date:  2015-09-30       Impact factor: 9.623

Review 4.  Sarcoidosis: a rheumatologist's perspective.

Authors:  Senol Kobak
Journal:  Ther Adv Musculoskelet Dis       Date:  2015-10       Impact factor: 5.346

Review 5.  Treatment of Sarcoidosis.

Authors:  Robert P Baughman; Elyse E Lower
Journal:  Clin Rev Allergy Immunol       Date:  2015-08       Impact factor: 8.667

6.  Clinical Characteristics of Sarcoidosis Patients with Self-Reported Lymphoma: A US Nationwide Registry Study.

Authors:  Bashar N Alzghoul; Yazan Zayed; Ahmad Obeidat; Bara Alzghoul; Abdallah Naser; Abdul-Rahim Shilbayeh; Ayoub Innabi; Tamara Al-Hakim; Mindy Buchanan; Borna Mehrad; Divya C Patel
Journal:  Lung       Date:  2021-10-19       Impact factor: 2.584

7.  Refractory pulmonary sarcoidosis - proposal of a definition and recommendations for the diagnostic and therapeutic approach.

Authors:  Peter Korsten; Katharina Strohmayer; Robert P Baughman; Nadera J Sweiss
Journal:  Clin Pulm Med       Date:  2016-03

Review 8.  [Sarcoidosis].

Authors:  B C Frye; J C Schupp; T C Köhler; R E Voll; J Müller-Quernheim
Journal:  Z Rheumatol       Date:  2016-05       Impact factor: 1.372

Review 9.  Challenges in Cardiac and Pulmonary Sarcoidosis: JACC State-of-the-Art Review.

Authors:  Maria Giovanna Trivieri; Paolo Spagnolo; David Birnie; Peter Liu; Wonder Drake; Jason C Kovacic; Robert Baughman; Zahi A Fayad; Marc A Judson
Journal:  J Am Coll Cardiol       Date:  2020-10-20       Impact factor: 24.094

10.  Effects of infliximab on lung and circulating natural killer cells, CD56+ T cells and B cells in sarcoidosis.

Authors:  Susanna Kullberg; Natalia V Rivera; Johan Grunewald; Anders Eklund
Journal:  BMJ Open Respir Res       Date:  2021-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.